title: Safe bridging to warfarin in heparin-induced thrombocytopenia.
authors.affiliation: Center for Clinical Transfusion Medicine, University Hospital of Tuebingen, Germany. Electronic address: tamam.bakchoul@med.uni-tuebingen.de.
authors.forename: Tamam
authors.initials: T
authors.lastname: Bakchoul
authors.affiliation: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014812:Vitamin K; D014859:Warfarin; D006493:Heparin
keywords: Heparin; Thrombocytopenia; Thrombosis; Warfarin